Filing excerpt
In April 2026, we terminated the 2023 ATM program and did not sell any shares under this program, and created the 2026 ATM program through which we can, but have no obligation to, sell common shares and we may also enter into separate forward sale agreements with forward purchasers for an aggregate offering price of up to $500.0 million.